Premier Biosoft has acquired privately held bioinformatics company Redasoft in an effort to expand its life sciences software business.
Redasoft markets sequence analysis software dubbed Visual Cloning, which includes vector map drawing capabilities and lets users create graphical maps based on sequence data. It also provides tools for restriction site analysis as well as to search for open reading frames.
Palo Alto, Calif.-based Premier, which is also privately held, expects the new acquisition to expand its reach in the life science software market.
“The acquisition of Redasoft demonstrates our strategy to strengthen our presence in the life science sector and deliver sustainable ... growth by offering a wide portfolio of products and services,” Kay Brown, Premier's president, said in a statement.
Premier offers software products and services for PCR and real time PCR, cloning, DNA and tissue microarrays, suspension bead arrays, glycomics, and mutagenesis. Its primary customers are government agencies, pharmaceutical and biotechnology companies, and academic researchers.
Additional details about the acquisition were not provided.